Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Test crawled date : 2021 - 11 - 22 save search
Walker & Dunlop Releases Latest Research with Launch of its Fall Multifamily Outlook
Published: 2021-11-22 (Crawled : 23:00) - prnewswire.com
WD 4 | $94.04 0.1% 0.0% 120K
|
Finance
|
| O: 0.27%
H: 0.93%
C: 0.43%
test research
Sorrento Therapeutics Mexico Executes Contract for Sale of 5 Million COVI-STIX Tests for Mexico Market
Published: 2021-11-22 (Crawled : 20:00) - globenewswire.com
SRNE | $0.02 33.33% -8.85% 97K
|
Health Technology
|
| O: -0.49%
H: 0.16%
C: -3.41%
test contract therapeutics
Biocept Launches Combined COVID-19 and Influenza Test to Provide Answers During Peak Flu Season
Published: 2021-11-22 (Crawled : 14:30) - biospace.com/
BIOC | $0.4349 -10.32% 750K
|
Health Services
|
| O: -1.4%
H: 8.26%
C: 0.57%
covid test influenza covid-19
Good Gaming Inc. Announces Latest Updates For Its NFT Game MicroBuddies™ And The Release Of Its New Beta 2.0
Published: 2021-11-22 (Crawled : 14:30) - globenewswire.com
GMER | $0.0177 -1.12% 159.63% 250K
|
Information
|
| O: 0.13%
H: 0.0%
C: -8.68%
test
Latch Ranked Number 101 on the 2021 Deloitte Technology Fast 500™ List of the Fastest-Growing Companies in North America
Published: 2021-11-22 (Crawled : 14:00) - globenewswire.com
LTCH | $0.54 4.86% 36K
|
Information
|
| O: 0.82%
H: 0.0%
C: 0.0%
test growing technology
Check-Cap Announces Publication of Peer-Reviewed Article Highlighting Safety and Patient Satisfaction Data for its Colorectal Screening Test, C-Scan®
Published: 2021-11-22 (Crawled : 13:00) - ir.check-cap.com
CHEK | $2.22 -3.06% -0.89% 24K
|
Health Technology
|
| O: 2.44%
H: 0.96%
C: -9.19%
scan test
Deciphera Receives European Commission Approval of QINLOCK® for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Published: 2021-11-22 (Crawled : 12:30) - biospace.com/
DCPH | $14.62 -0.34% -0.48% 400K
|
Health Technology
|
| O: 4.9%
H: 0.33%
C: -3.78%
qinlock treatment europe test gastrointestinal approval
Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Testing in Breast Cancer Risk Assessment and Treatment
Published: 2021-11-22 (Crawled : 12:30) - globenewswire.com
MYGN | $18.63 0.16% 0.05% 480K
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
treatment genetic risk test cancer breast cancer symposium
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.